Matinas BioPharma Holdings, Inc(MTNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MTNB Matinas BioPharma Holdings, Inc

交易中 07-23 13:59:46 EDT

0.2502

-0.0170

-6.36%

最高0.2750	最低0.2426	成交量18.01万
今开0.2511	昨收0.2672	日振幅12.13%
总市值160.28万	流通市值107.78万	总股本640.62万
成交额4.52万	换手率4.18%	流通股本430.77万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MTNB","market":"US","secType":"STK","nameCN":"Matinas BioPharma Holdings, Inc","latestPrice":0.2502,"timestamp":1784829420493,"preClose":0.2672,"halted":0,"volume":180056,"delay":0,"changeRate":-0.06362275449101802,"floatShares":4307733,"shares":6406191,"eps":-1.93455,"marketStatus":"交易中","change":-0.017,"latestTime":"07-23 13:59:46 EDT","open":0.2511,"high":0.275,"low":0.2426,"amount":45243.07264488,"amplitude":0.121257,"askPrice":0.2637,"askSize":200,"bidPrice":0.2444,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.93455,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784836800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":0.2672,"preHourTrading":{"tag":"盘前","latestPrice":0.2571,"preClose":0.2672,"latestTime":"09:29 EDT","volume":5032,"amount":1311.47295056,"timestamp":1784813341438,"change":-0.0101,"changeRate":-0.037799,"amplitude":0.048278},"postHourTrading":{"tag":"盘后","latestPrice":0.2655,"preClose":0.2672,"latestTime":"19:52 EDT","volume":12935,"amount":3414.108,"timestamp":1784764323503,"change":-0.0017,"changeRate":-0.006362,"amplitude":0.061568},"volumeRatio":0.317029},"requestUrl":"/m/hq/s/MTNB","defaultTab":"news","newsList":[{"id":"1190759589","title":"GH Power——清洁能源与关键材料领域的先锋企业，拟通过与Matinas BioPharma合并实现上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1190759589","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190759589?lang=zh_cn&edition=full","pubTime":"2026-07-14 03:49","pubTimestamp":1783972154,"startTime":"0","endTime":"0","summary":"GH Power，一家在清洁能源与关键材料领域处于先锋地位的企业，宣布计划通过与Matinas BioPharma Holdings, Inc进行业务合并的方式，完成公开上市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178295115","title":"Matinas BioPharma Holdings - 每股普通股将转换为0.1股GHP International普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1178295115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178295115?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:04","pubTimestamp":1783944268,"startTime":"0","endTime":"0","summary":"Matinas BioPharma Holdings, Inc宣布，其每股普通股将按比例转换为0.1股GHP International普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176999148","title":"Matinas BioPharma拟议交易：获400万美元预付款，潜在里程碑付款最高1750万美元及未来中个位数特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1176999148","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176999148?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:02","pubTimestamp":1783944179,"startTime":"0","endTime":"0","summary":"Matinas BioPharma Holdings, Inc. 披露了一项拟议交易，公司将获得400万美元的预付款，并可依据后续潜在里程碑的实现情况，额外获取最高达1750万美元的款项。此外，公司还有权获得未来销售额的中个位数百分比作为特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154013182","title":"Matinas Biopharma Holdings与GH Power股东将分别持有合并后Ghp International 9%与91%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1154013182","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154013182?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:02","pubTimestamp":1783944177,"startTime":"0","endTime":"0","summary":"根据交易完成后的股权结构安排，Matinas BioPharma Holdings的现有股东预计将持有新成立的Ghp International公司9%的股权，而GH Power的股东则将获得高达91%的控股权益。这一股权分配方案明确了双方在合并实体中的所有权比例，标志着企业整合进程中的关键一步。后续的公司运营与战略方向或将由控股股东主导推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109286083","title":"Matinas BioPharma宣布与GH Power达成战略业务合并，组建先进清洁能源及绿氢上市公司；签署最终协议向Azurity Pharmaceuticals出售Lnc平台技术及主导候选产品Mat2203","url":"https://stock-news.laohu8.com/highlight/detail?id=1109286083","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109286083?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:02","pubTimestamp":1783944140,"startTime":"0","endTime":"0","summary":"Matinas BioPharma Holdings, Inc宣布了一项重大战略举措，将与GH Power进行业务合并，共同组建一家专注于先进清洁能源与绿色氢能的上市公司。此举标志着该公司业务方向的重大转型。\n与此同时，Matinas BioPharma已与Azurity Pharmaceuticals签署最终协议，将其Lnc平台技术及主导候选药物Mat2203出售给后者。这项交易旨在优化公司资产结构，将资源集中于新兴的清洁能源领域。\n通过这一系列战略布局，Matinas BioPharma旨在构建一个全新的业务框架，在推动绿色氢能等清洁技术发展的同时，完成对原有生物制药资产的有序剥离。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107387193","title":"Matinas BioPharma 收到不符合 NYSE American 持续上市标准通知 并提交恢复合规计划获接纳","url":"https://stock-news.laohu8.com/highlight/detail?id=1107387193","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107387193?lang=zh_cn&edition=full","pubTime":"2026-06-27 05:17","pubTimestamp":1782508635,"startTime":"0","endTime":"0","summary":"Matinas BioPharma Holdings, Inc (MTNB) 已收到纽约证券交易所美国公司（NYSE American）发出的通知，指出其当前未能符合该交易所的持续上市标准。与此同时，该公司提交的旨在恢复合规状态的计划已获得交易所接纳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159156009","title":"Matinas BioPharma Holdings, Inc 首席财务官基思·库辛斯基将于2026年1月17日卸任 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1159156009","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159156009?lang=zh_cn&edition=full","pubTime":"2026-01-24 06:08","pubTimestamp":1769206094,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，Matinas BioPharma Holdings, Inc宣布其首席财务官基思·库辛斯基已提交辞呈，卸任生效日期定为2026年1月17日。Matinas BioPharma Holdings, Inc 强调，此次人事变动不会影响公司现有财务战略及日常运营的稳定性。作为一家专注于创新疗法开发的生物制药企业，Matinas BioPharma Holdings, Inc 将持续推进其管线药物的研发进程，管理层变动细节将依据监管要求适时对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516666591","title":"Matinas Biopharma Holdings, Inc.盘中异动 临近收盘快速下跌5.07%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516666591?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:54","pubTimestamp":1741035299,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时54分，Matinas Biopharma Holdings, Inc.股票出现异动，股价快速下跌5.07%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4697.63%、219.82%、190.63%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045459abe69d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045459abe69d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514043640","title":"Matinas Biopharma Holdings, Inc.盘中异动 股价大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514043640?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:07","pubTimestamp":1740510475,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时07分，Matinas Biopharma Holdings, Inc.股票出现波动，股价快速下跌6.79%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Organovo Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1951.28%、1166.75%、997.60%，振幅较大的相关个股有Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp，振幅分别为241.19%、112.90%、87.83%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226030755a253c582&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226030755a253c582&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720660","title":"Matinas Biopharma Holdings, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720660?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:50","pubTimestamp":1740408613,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时50分，Matinas Biopharma Holdings, Inc.股票出现波动，股价大幅下跌5.08%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为125.89%、53.75%、24.85%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Immunic, Inc.，振幅分别为137.23%、21.42%、20.47%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225014962e9d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225014962e9d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513277290","title":"Matinas Biopharma Holdings, Inc.盘中异动 股价大涨6.53%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513277290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513277290?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:01","pubTimestamp":1740157309,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时01分，Matinas Biopharma Holdings, Inc.股票出现波动，股价快速上涨6.53%。截至发稿，该股报0.620美元/股，成交量12.8584万股，换手率2.53%，振幅8.40%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222010150962b9caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222010150962b9caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512443395","title":"Matinas Biopharma Holdings, Inc.盘中异动 快速下挫7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512443395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512443395?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:37","pubTimestamp":1739990234,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时37分，Matinas Biopharma Holdings, Inc.股票出现波动，股价大幅下跌7.02%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为664.34%、253.55%、224.35%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为267.43%、159.49%、61.99%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023715abd52a78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023715abd52a78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511257115","title":"Matinas Biopharma Holdings, Inc.盘中异动 股价大涨5.22%报0.617美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511257115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511257115?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:44","pubTimestamp":1739457842,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时44分，Matinas Biopharma Holdings, Inc.股票出现波动，股价大幅拉升5.22%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Pliant Therapeutics, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Moleculin Biotech, Inc.较为活跃，换手率分别为1084.78%、1042.78%、254.90%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Moleculin Biotech, Inc.，振幅分别为69.33%、56.44%、56.19%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224402abcdb498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224402abcdb498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510339370","title":"Matinas Biopharma Holdings, Inc.盘中异动 早盘股价大涨8.37%报0.644美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510339370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510339370?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:35","pubTimestamp":1739288131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时35分，Matinas Biopharma Holdings, Inc.股票出现异动，股价急速上涨8.37%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2668.91%、1043.22%、364.53%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112335319881c918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112335319881c918&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510637768","title":"Matinas Biopharma Holdings, Inc.盘中异动 快速拉升5.39%报0.665美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510637768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510637768?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:34","pubTimestamp":1739198072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时34分，Matinas Biopharma Holdings, Inc.股票出现异动，股价大幅拉升5.39%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为933.88%、612.15%、257.82%，振幅较大的相关个股有Invivyd, Inc.、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为29.90%、26.71%、22.45%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223432abc9a5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223432abc9a5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTNB","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509474019","title":"Matinas Biopharma Holdings, Inc.盘中异动 急速上涨5.10%报0.610美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509474019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509474019?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:25","pubTimestamp":1738941902,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时25分，Matinas Biopharma Holdings, Inc.股票出现波动，股价大幅上涨5.10%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为4062.29%、131.16%、82.41%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、46.71%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207232502abc6370d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207232502abc6370d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509496465","title":"Matinas Biopharma Holdings, Inc.盘中异动 下午盘急速跳水6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509496465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509496465?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:03","pubTimestamp":1738699384,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时03分，Matinas Biopharma Holdings, Inc.股票出现异动，股价急速下跌6.95%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Mink Therapeutics, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1933.57%、987.10%、586.50%，振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Mink Therapeutics, Inc.，振幅分别为123.99%、59.42%、58.27%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504030496180af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020504030496180af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507964334","title":"Matinas Biopharma Holdings, Inc.盘中异动 早盘股价大跌5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507964334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507964334?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:37","pubTimestamp":1738337865,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时37分，Matinas Biopharma Holdings, Inc.股票出现波动，股价急速跳水5.92%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1850.65%、1811.40%、138.37%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为63.20%、56.30%、51.82%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312337459614f347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312337459614f347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507565673","title":"Matinas Biopharma Holdings, Inc.盘中异动 急速跳水8.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507565673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507565673?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:24","pubTimestamp":1738254294,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时24分，Matinas Biopharma Holdings, Inc.股票出现波动，股价快速下挫8.36%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1636.88%、231.84%、210.58%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为65.98%、61.86%、56.41%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310024549876becb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310024549876becb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506512904","title":"Matinas Biopharma Holdings, Inc.盘中异动 早盘大幅拉升5.11%报0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506512904?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:37","pubTimestamp":1738075072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时37分，Matinas Biopharma Holdings, Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报0.660美元/股，成交量7896股，换手率0.16%，振幅2.25%。Matinas Biopharma Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Matinas Biopharma Holdings, Inc.公司简介：Matinas BioPharma Holdings Inc是一家临床阶段的生物制药公司，专注于识别和开发新型医药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822375298756c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822375298756c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.matinasbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.2157},{"period":"1month","weight":-0.5765},{"period":"3month","weight":-0.5669},{"period":"6month","weight":-0.6289},{"period":"1year","weight":-0.7188},{"period":"ytd","weight":-0.544}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Matinas Biopharma Holdings, Inc.是一家于2013年5月成立的特拉华州公司。该公司是一家临床阶段的生物制药公司，专注于使用脂质纳米晶体（LNC）平台递送技术（LNC平台）提供突破性疗法。该公司正在开发一系列产品和开发候选产品，最初的重点是严重的真菌和细菌感染。该公司专有的人工耳蜗递送技术平台，从罗格斯大学获得全球独家许可，专门设计用于将药物直接靶向和安全递送到感染或炎症部位。这一创新技术利用脂质晶体纳米颗粒的Cochleates纳米封装来封装现有药物，旨在使更安全、更耐受、毒性更低和口服生物可利用性更强。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.03777},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.019834},{"month":3,"riseRate":0.111111,"avgChangeRate":-0.098296},{"month":4,"riseRate":0.4,"avgChangeRate":-0.020712},{"month":5,"riseRate":0.5,"avgChangeRate":0.033278},{"month":6,"riseRate":0.3,"avgChangeRate":-0.087842},{"month":7,"riseRate":0.3,"avgChangeRate":-0.112321},{"month":8,"riseRate":0.555556,"avgChangeRate":0.044617},{"month":9,"riseRate":0.444444,"avgChangeRate":0.10663},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.022816},{"month":11,"riseRate":0.555556,"avgChangeRate":0.048777},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.003532}],"exchange":"AMEX","name":"Matinas BioPharma Holdings, Inc","nameEN":"Matinas BioPharma Holdings, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Matinas BioPharma Holdings, Inc(MTNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Matinas BioPharma Holdings, Inc(MTNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Matinas BioPharma Holdings, Inc,MTNB,Matinas BioPharma Holdings, Inc股票,Matinas BioPharma Holdings, Inc股票老虎,Matinas BioPharma Holdings, Inc股票老虎国际,Matinas BioPharma Holdings, Inc行情,Matinas BioPharma Holdings, Inc股票行情,Matinas BioPharma Holdings, Inc股价,Matinas BioPharma Holdings, Inc股市,Matinas BioPharma Holdings, Inc股票价格,Matinas BioPharma Holdings, Inc股票交易,Matinas BioPharma Holdings, Inc股票购买,Matinas BioPharma Holdings, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Matinas BioPharma Holdings, Inc(MTNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Matinas BioPharma Holdings, Inc(MTNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}